Authors:
Koster, A
Loebe, M
Sodian, R
Potapov, EV
Hansen, R
Muller, J
Mertzlufft, F
Crystal, GJ
Kuppe, H
Hetzer, R
Citation: A. Koster et al., Heparin antibodies and thromboembolism in heparin-coated and noncoated ventricular assist devices, J THOR SURG, 121(2), 2001, pp. 331-335
Authors:
Kleinschmidt, S
Mertzlufft, F
Bach, F
Plinkert, RK
Citation: S. Kleinschmidt et al., Heparin-induced thrombocytopenia (HIT) - Problem and their importance for ENT medicine, HNO, 49(10), 2001, pp. 854-864
Authors:
Koster, A
Kulucka, M
Bach, F
Meyer, O
Fischer, T
Mertzlufft, F
Loebe, M
Hetzer, R
Kuppe, H
Citation: A. Koster et al., Anticoagulation during cardiopulmonary bypass in patients with heparin-induced thrombocytopenia type II and renal impairment using heparin and the platelet glycoprotein IIb-IIIa antagonist tirofiban, ANESTHESIOL, 94(2), 2001, pp. 245-251
Authors:
Koster, A
Sanger, S
Hansen, R
Sodian, R
Mertzlufft, F
Harke, C
Kuppe, H
Hetzer, R
Loebe, M
Citation: A. Koster et al., Prevalence and persistence of heparin/platelet factor 4 antibodies in patients with heparin coated and noncoated ventricular assist devices, ASAIO J, 46(3), 2000, pp. 319-322
Authors:
Koster, A
Hansen, R
Kuppe, H
Hetzer, R
Crystal, GJ
Mertzlufft, F
Citation: A. Koster et al., Recombinant hirudin as an alternative for anticoagulation during cardiopulmonary bypass in patients with heparin-induced thrombocytopenia type II: A 1-year experience in 57 patients, J CARDIOTHO, 14(3), 2000, pp. 243-248
Authors:
Koster, A
Hansen, R
Grauhan, O
Hausmann, H
Bauer, M
Hetzer, R
Kuppe, H
Mertzlufft, F
Citation: A. Koster et al., Hirudin monitoring using the TAS ecarin clotting time in patients with heparin-induced thrombocytopenia type II, J CARDIOTHO, 14(3), 2000, pp. 249-252
Citation: F. Mertzlufft et al., Management of urgent high-risk cardiopulmonary bypass in patients with heparin-induced thrombocytopenia type II and coexisting disorders of renal function: Use of heparin and epoprostenol combined with on-line monitoring of platelet function, J CARDIOTHO, 14(3), 2000, pp. 304-308
Authors:
Koster, A
Meyer, O
Hausmann, H
Kuppe, H
Hetzer, R
Mertzlufft, F
Citation: A. Koster et al., In vitro cross-reactivity of danaparoid sodium in patients with heparin-induced thrombocytopenia type II undergoing cardiovascular surgery, J CLIN ANES, 12(4), 2000, pp. 324-327
Authors:
Koster, A
Loebe, M
Hansen, R
Bauer, M
Mertzlufft, F
Kuppe, H
Hetzer, R
Citation: A. Koster et al., A quick assay for monitoring recombinant hirudin during cardiopulmonary bypass in patients with heparin-induced thrombocytopenia type II: Adaptation of the ecarin clotting time to the ACT II device, J THOR SURG, 119(6), 2000, pp. 1278-1283
Authors:
Koster, A
Loebe, M
Mertzlufft, F
Kuppe, H
Hetzer, R
Citation: A. Koster et al., Cardiopulmonary bypass in a patient with heparin-induced thrombocytopenia II and impaired renal function using heparin and the platelet GP IIb/IIIa inhibitor tirofiban as anticoagulant, ANN THORAC, 70(6), 2000, pp. 2160-2161
Authors:
Mertzlufft, F
Koster, A
Hansen, R
Risch, A
Kuppe, H
Kubel, B
Crystal, GJ
Citation: F. Mertzlufft et al., Reliability of the heparin management test for monitoring high levels of unfractionated heparin - In vitro findings in volunteers versus in vivo findings during cardiopulmonary bypass, ANESTHESIOL, 92(6), 2000, pp. 1594-1602
Authors:
Hansen, R
Koster, A
Kukucka, M
Mertzlufft, F
Kuppe, H
Citation: R. Hansen et al., A quick anti-Xa-activity-based whole blood coagulation assay for monitoring unfractionated heparin during cardiopulmonary bypass: A pilot investigation, ANESTH ANAL, 91(3), 2000, pp. 533-538
Authors:
Koster, A
Merkle, F
Hansen, R
Loebe, M
Kuppe, H
Hetzer, R
Crystal, GJ
Mertzlufft, F
Citation: A. Koster et al., Elimination of recombinant hirudin by modified ultrafiltration during simulated cardiopulmonary bypass: Assessment of different filter systems, ANESTH ANAL, 91(2), 2000, pp. 265-269
Authors:
Koster, A
Kuppe, H
Crystal, GJ
Mertzlufft, F
Citation: A. Koster et al., Cardiovascular surgery without cardiopulmonary bypass in patients with heparin-induced thrombocytopenia type II using anticoagulation with recombinant hirudin, ANESTH ANAL, 90(2), 2000, pp. 292-298
Citation: A. Risch et al., Preanalytical errors on the termination of arterial O-2-partial pressure and their impact on the AaDO(2), ANAESTHESIS, 49(1), 2000, pp. 29-33
Authors:
Steinhart, H
Kuhn-Lohmann, J
Gewalt, K
Constantnidis, J
Mertzlufft, F
Iro, H
Citation: H. Steinhart et al., Upper airway collapsibility in habitual snorers and sleep apneics: Evaluation with drug-induced sleep endoscopy, ACT OTO-LAR, 120(8), 2000, pp. 990-994
Authors:
Schlaich, N
Mertzlufft, F
Soltesz, S
Fuchs-Buder, T
Citation: N. Schlaich et al., Remifentanil and propofol without muscle relaxants or with different dosesof rocuronium for tracheal intubation in outpatient anaesthesia, ACT ANAE SC, 44(6), 2000, pp. 720-726
Authors:
Bauer, C
Walcher, F
Holanda, M
Mertzlufft, F
Larsen, R
Marzi, I
Citation: C. Bauer et al., Antioxidative resuscitation solution prevents leukocyte adhesion in the liver after hemorrhagic shock, J TRAUMA, 46(5), 1999, pp. 886-893
Authors:
Kleinschmidt, S
Schellhase, C
Mertzlufft, F
Citation: S. Kleinschmidt et al., Continuous sedation during spinal anaesthesia: gamma-hydroxybutyrate vs. propofol, EUR J ANAES, 16(1), 1999, pp. 23-30
Authors:
Constantinidis, J
Mertzlufft, F
Steinhart, H
Citation: J. Constantinidis et al., Acute unilateral deafness and contralateral hearing loss following inguinal hernia repair under controlled anesthesia, HNO, 47(10), 1999, pp. 907-911
Citation: A. Risch et al., Pre-analytic errors in the determination of arterial O-2-partial pressure under hyperoxic conditions, ANAESTHESIS, 48(8), 1999, pp. 533-537
Citation: A. Biedler et al., Evaluation of lactate measurement in blood and plasma with biosensor technology: a comparison of methods, ANAESTHESIS, 47(12), 1998, pp. 968-974